Last edition
News about
Income Tax Survey at Ipca Laboratories Ltd's plants
The Income Tax Department has carried out survey proceedings at the Company's offices in Mumbai and at Sikkim manufacturing plants between 30th May, 2023 to 3rd June, 2023.
PAG-led Sekhmet Pharmaventures announces hiring of Anil Khubchandani as MD and CEO
Accomplished industry executive to lead platform on next stage of growth
Lupin receives approval from U.S. FDA for Diazepam Rectal Gel
Global pharma major Lupin Limited (Lupin) today announced that its wholly-owned subsidiary, Novel Laboratories Inc., based in Somerset, New Jersey, has received approval from the United States Food and Drug Administration (U.S. FDA)
US FDA inspection completed at Caplin Steriles Injectable site at Gummidipoondi
Caplin Point Laboratories Limited has announced that the United States Food and Drug Administration (USFDA) had completed its GMP and PAI inspection of Caplin Steriles Limited's (a subsidiary of Caplin Point Laboratories Limited) Sterile Injectable site at Gummidipoondi between May 22nd to 31st.
Laurus Labs to increase stake in ImmunoACT to 33.86%
Laurus Labs to increase stake in ImmunoACT to 33.86%
Chugai to make big investment in new bio manufacturing facilities
Japanese drugmaker Chugai Pharmaceuticals (TYO: 4519) has decided to invest over 50 billion yen ($356 million) in total for two new manufacturing facilities at the Utsunomiya plant.
Plasmagen Biosciences Inaugurates New Manufacturing Facility for Blood Plasma Products in Kolar
PlasmaGen Biosciences (PlasmaGen), a biopharmaceutical company recently celebrated the official opening of its new production facility for blood plasma-derived protein therapeutics in Kolar, Bengaluru.
UCB Pharma Receives FDA Form 483 in Belgium
The FDA issued a Form 483 to UCB Pharma, a biopharma business with headquarters in Belgium after an examination revealed problems with its quality control unit and product storage.
PlasmaGen Biosciences ('PlasmaGen'), a biopharmaceutical company focused on blood plasma-derived pharmaceutical products for India and emerging markets, recently celebrated the official opening of the company's new manufacturing plant for blood plasma-derived protein therapeutics in Kolar, Bengaluru.
Belgium's UCB Pharma hit with FDA Form 483 after April inspection
UCB Pharma, a Belgium-based biopharma company, has been slapped with a Form 483 from the FDA following an inspection that uncovered issues with its quality control unit and product storage.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy